Safety profile of ORTHO-R confirmed.Statistical significance over standard of care demonstrated.ORTHO-R program advancing towards clinical phase. MONTREAL, March 12, 2020 /CNW/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTI” or the “Company“), an emerging orthobiologics company, today announced positive results following completion of its pivotal preclinical study in Rotator Cuff Tear repair. The results confirmed the safety …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone